FDA Recall Terminated

Simplexa Flu AlB & RSV Direct Assay Kits, intended for use as an aid in the differential diagnosis of influenza A, influenza B, and RSV viral infections in humans and is not intended to detect influenza C. Model Number MOL2650.

Recall: Z-1144-2014 · Initiated February 4, 2014

Recall

Recall Number
Z-1144-2014
Event Number
67436
Firm
Focus Diagnostics Inc
FEI Number
2023365
Product Code
OOC
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
February 4, 2014
Posted
March 5, 2014
Terminated
November 1, 2014
Address
11331 Valley View St, Cypress, CA, 90630-5366

Description

Simplexa Flu AlB & RSV Direct Assay Kits, intended for use as an aid in the differential diagnosis of influenza A, influenza B, and RSV viral infections in humans and is not intended to detect influenza C. Model Number MOL2650.

Reason

Focus Diagnostics initiated the recall of the certain Simplexa Flu AlB & RSV Direct assay kits due to the potential of false positive Flu A, Flu B and RSV signals.

Action

Focus Diagnostic initiated this recall on February 4, 2014 by sending recall notification letters to customers via email. The letter dated February 4, 2014, titled "URGENT: SAFETY NOTICE REMOVAL", informed customers of the recall (removal). The letter provided the following information: product description with code, reason for recall, the issue, the risk to health, recommendation, background, actions by customers, contact information, labeling, and response sheet.

Distribution

Worldwide Distribution: US (nationwide) and to countries of:Canada, Sweden, Belgium, Spain, Portugal, Slovenia, and Israel.

Quantity

2,175 kits